Evidence map›Paper›PMID 16341883›Full record

ArticleParasitology research2006

Could the homologous sequence of anti-inflammatory pentapeptide (MLIF) produced by Entamoeba histolytica in the N protein of rabies virus affect the inflammatory process?

M E Morales, G Rico, J L Gómez, R Alonso, R Cortés, R Silva, J A Giménez, R Kretschmer, A Aguilar-Setién

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Rabies surveillance in the United States during 2010.Journal of the American Veterinary Medical Association · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

M E MoralesUnidad de Investigación Médica en Inmunología, Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, DF, Mexico. estmormag@hotmail.com
G Rico
J L Gómez
R Alonso
R Cortés
R Silva
J A Giménez
R Kretschmer
A Aguilar-Setién
Centro Medico Nacional Siglo XXI · MXFundação de Estudo e Pesquisa em Medicina Veterinária e Zootecnia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amebiasis and rabies are public health problems, and they have in common a poor inflammatory effect in the target organs that they affect. In the GenBank, it was found that the anti-inflammatory peptide monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica homologates 80%, with a fragment of the N protein of the rabies virus. We speculated if the N protein could contribute to the scant inflammatory reaction produced by rabies virus in central nervous system. The N protein was obtained and studied in vitro and in vivo. The N protein, as MLIF, inhibited the respiratory burst in human mononuclear phagocytes (43%, p<0.05), but in contrast to MLIF, it increased chemotaxis and it did not significantly inhibit delayed hypersensitivity skin reaction to 1-chloro-2-4-dinitrobenzene in guinea pigs. Therefore, the full peptide sequence has to be present or it has to be cleaved-free from the large recombinant N protein molecule (55 kDa) to become active.

Indexed as

AnimalsCell LineCell MovementChemotactic FactorsEntamoeba histolyticaGuinea PigsHypersensitivity, DelayedInflammationMothsNucleocapsid ProteinsOligopeptidesProtozoan ProteinsRespiratory BurstChemotactic Factorsmonocyte locomotion inhibitory factornucleocapsid protein, Rabies virusNucleocapsid ProteinsOligopeptidesProtozoan Proteins

Identifiers

PMID16341883
OpenAlexW2023593590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.